Low miR-210 and CASP8AP2 expression is associated with a poor outcome in pediatric acute lymphoblastic leukemia

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• MicroRNA-210 (miR-210) and CASP8AP2 gene expression are validated prognostic indicators in pediatric acute lymphoblastic leukemia (ALL).
• CASP8AP2 is a validated target of miR-210, suggesting a regulatory relationship relevant to ALL.
• Accurate prognostic markers are crucial for optimizing treatment strategies in pediatric ALL.

Purpose of the Study:

• To investigate the prognostic significance of miR-210 and CASP8AP2 expression in pediatric ALL.
• To analyze the association between miR-210 and CASP8AP2 expression levels and ALL prognosis.
• To develop a predictive model for bone marrow relapse in pediatric ALL.

Main Methods:

• Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was employed to quantify miR-210 and CASP8AP2 expression in 91 pediatric ALL patients.
• Statistical analyses were performed to assess the association between gene expression and prognostic value.
• Receiver operating characteristic (ROC) curve analysis determined optimal threshold values for miR-210 and CASP8AP2.

Main Results:

• No significant association was found between miR-210 and CASP8AP2 mRNA levels in pediatric ALL.
• Combined detection of miR-210 and CASP8AP2 significantly improved the accuracy of ALL prognosis prediction.
• A predictive equation incorporating minimal residual disease at day 33, miR-210, and CASP8AP2 expression was developed.

Conclusions:

• The combined assessment of miR-210 and CASP8AP2 offers enhanced prognostic accuracy in pediatric ALL.
• The developed predictive equation may enable more precise forecasting of bone marrow relapse compared to existing risk stratification methods.
• Further validation of this novel predictive model is warranted for clinical application in pediatric ALL management.